title: Conjugation of the Bowman-Birk soybean proteinase inhibitor with hydroxyethylstarch.
abstract: The classical Bowman-Birk soybean proteinase inhibitor was modified by hydroxyethylstarch. The modified inhibitor retained the capacity for simultaneous binding of trypsin and human leukocyte elastase. The inhibition constants, Ki, of bovine trypsin, alpha-chymotrypsin and human leukocyte elastase (HLE) increased not more than 10-, 1.5-, and 20-fold, respectively, on modification of the inhibitor. The less effective inhibition is presumably due to the steric hindrance brought about by the conjugation with polysaccharide molecules. The results obtained indicate the pronounced structure differences of the binding regions for trypsin and chymotrypsin/leukocyte elastase in the modified preparation.
authors.affiliation: Department of Chemistry, M.V. Lomonosov Moscow State University, Russia.
authors.forename: N I
authors.initials: NI
authors.lastname: Larionova
authors.forename: S S
authors.initials: SS
authors.lastname: Vartanov
authors.forename: N V
authors.initials: NV
authors.lastname: Sorokina
authors.forename: I P
authors.initials: IP
authors.lastname: Gladysheva
authors.forename: S D
authors.initials: SD
authors.lastname: Varfolomeyev
mesh_terms: D002918:Chymotrypsin / Q000037:antagonists & inhibitors; D006207:Half-Life; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000737:chemistry* / Q000493:pharmacokinetics / Q000627:therapeutic use; D019272:Leukocyte Elastase / Q000097:blood; D010940:Plant Proteins / Q000737:chemistry*; D010952:Plasma Substitutes / Q000737:chemistry* / Q000493:pharmacokinetics / Q000627:therapeutic use; D018805:Sepsis / Q000628:therapy; D012769:Shock / Q000628:therapy
chemical_list: C067589:FMTI-II protein, Setaria italica; D006895:Hydroxyethyl Starch Derivatives; D010940:Plant Proteins; D010952:Plasma Substitutes; D002918:Chymotrypsin; D019272:Leukocyte Elastase